Collection
Adjuvant Management of Surgically Resected Brain Tumors
- Submission status
- Closed
While the multidisciplinary team approach has been widely accepted in the management of CNS pathologies, the precise choice of treatments and the optimal sequence in which those are delivered remains patient-specific and the subject of considerable debate. Surgical resection, radiation, and systemic treatments ideally complement each other to provide the best overall survival and quality of life.
Advances in timing and modality of radiation delivery, along with the development of novel systemic agents and the ability to target those agents into the CNS, will continue to transform the landscape of CNS tumor management. To this end, multiple areas of novel clinical and pre-clinical research have matured to allow for comparative analysis against the historical treatment paradigms in which surgical resection is required. Thus far, publication of these data has been piecemeal, lacking in a cohesive and comprehensive presentation.
The current special issue will specifically address the advances in neurosurgical oncology beyond traditional standards of care, providing a modern evidence-based review along with novel content in burgeoning areas of CNS tumor management.
Editors
-
Christopher P. Cifarelli MD, PhD, MMM, FAANS, FACS
Dr. Cifarelli is an Associate Editor of the Journal of Neuro-oncology and a member of the Tumor Section Executive Committee of the American Association of Neurological Surgeons & Congress of Neurological Surgeons, where serves the Section’s liaison with ASTRO and Chair of the Innovation and Technology Committee. In addition to his clinical and service roles, Dr. Cifarelli runs a basic science research program dedicated to the identification of mechanisms for increasing radiation sensitivity in tumor models, having received funding support through the NIGMS at the NIH.
Articles (16 in this collection)
-
-
An exploratory prospective phase II study of preoperative neoadjuvant bevacizumab and temozolomide for newly diagnosed glioblastoma
Authors (first, second and last of 14)
- Toshihide Tanaka
- Ryota Tamura
- Hikaru Sasaki
- Content type: Case Study
- Open Access
- Published: 31 January 2024
- Pages: 557 - 567
-
GammaTile® (GT) as a brachytherapy platform for rapidly proliferating glioblastomas: from case series to clinical trials
Authors (first, second and last of 7)
- Anudeep Yekula
- Dominic J. Gessler
- Clark C. Chen
- Content type: Research
- Published: 28 January 2024
- Pages: 441 - 450
-
MRI Treatment Response Assessment Maps (TRAMs) for differentiating recurrent glioblastoma from radiation necrosis
Authors (first, second and last of 5)
- Sebastian Johannes Müller
- Eya Khadhraoui
- Georg Alexander Gihr
- Content type: Research
- Published: 23 January 2024
- Pages: 513 - 521
-
Laser interstitial thermal therapy for deep-seated perivascular brain tumors is not associated with distal ischemia
Authors (first, second and last of 12)
- Jared C. Reese
- Hassan A. Fadel
- Ian Y. Lee
- Content type: Research
- Published: 19 January 2024
- Pages: 265 - 272
-
The development of a combined clinico-radiomics model for predicting post-operative recurrence in atypical meningiomas: a multicenter study
Authors (first, second and last of 12)
- Leihao Ren
- Jiawei Chen
- Lingyang Hua
- Content type: Research
- Published: 26 December 2023
- Pages: 59 - 71
-
Ganciclovir as a potential treatment for glioma: a systematic review and meta-analysis
Authors (first, second and last of 5)
- Chun-Tao Chang
- Hsing-Hui Chen
- Nai-Wan Hsiao
- Content type: Review
- Published: 08 December 2023
- Pages: 399 - 411
-
Targeted immunotherapy for glioblastoma involving whole tumor-derived autologous cells in the upfront setting after craniotomy
Authors (first, second and last of 5)
- Carrie E. Andrews
- Jenny Zilberberg
- David W. Andrews
- Content type: Review
- Open Access
- Published: 29 November 2023
- Pages: 389 - 398
-
Correction to: Impact of boost sequence in concurrent chemo-radiotherapy on newly diagnosed IDH-wildtype glioblastoma multiforme
Authors (first, second and last of 15)
- Nalee Kim
- Joongyo Lee
- Hong In Yoon
- Content type: Correction
- Published: 08 November 2023
- Pages: 269 - 269
-
Preoperative stereotactic radiosurgery as neoadjuvant therapy for resectable brain tumors
Authors (first, second and last of 6)
- David Crompton
- Daniel Koffler
- Daniel M. Trifiletti
- Content type: Review
- Published: 27 October 2023
- Pages: 21 - 28
-
Impact of boost sequence in concurrent chemo-radiotherapy on newly diagnosed IDH-wildtype glioblastoma multiforme
Authors (first, second and last of 15)
- Nalee Kim
- Joongyo Lee
- Hong In Yoon
- Content type: Research
- Published: 20 October 2023
- Pages: 261 - 268
-
The role of cytoreductive surgery in multifocal/multicentric glioblastomas
Authors (first, second and last of 6)
- Diyan Dimov
- Daniel Brainman
- Matthias Simon
- Content type: Case Study
- Open Access
- Published: 12 September 2023
- Pages: 447 - 459
-
Intracranial intraoperative radiotherapy (IORT): evaluation of electrocorticography and peri-operative seizure risk
Authors (first, second and last of 6)
- Christopher P. Cifarelli
- John A. Vargo
- Aman Dabir
- Content type: Research
- Published: 05 September 2023
- Pages: 423 - 430
-
Intraoperative or postoperative stereotactic radiotherapy for brain metastases: time to systemic treatment onset and other patient-relevant outcomes
Authors (first, second and last of 23)
- Cas S. Dejonckheere
- Julian P. Layer
- Gustavo R. Sarria
- Content type: Research
- Open Access
- Published: 09 October 2023
- Pages: 683 - 691
-
Outcome assessment of intraoperative radiotherapy for brain metastases: results of a prospective observational study with comparative matched-pair analysis
Authors (first, second and last of 26)
- Julian P. Layer
- Motaz Hamed
- L. Christopher Schmeel
- Content type: Research
- Open Access
- Published: 21 July 2023
- Pages: 107 - 116
-
Hypo-fractionated accelerated radiotherapy with concurrent and maintenance temozolomide in newly diagnosed glioblastoma: updated results from phase II HART-GBM trial
Authors (first, second and last of 10)
- Supriya Mallick
- Subhash Gupta
- Goura Kishor Rath
- Content type: Research
- Published: 15 July 2023
- Pages: 141 - 146